#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid antibodies Mantle cell lymphoma stage IV Glioblastoma Thyroid cancer metastatic Oesophageal carcinoma Diffuse large B-cell lymphoma Mixed-type liposarcoma Mycobacterium abscessus infection Congenital growth hormone deficiency Cataract Urea cycle disorder Oesophageal squamous cell carcinoma stage III Encephalitis autoimmune Pustular psoriasis Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    CADASIL Cystic fibrosis lung – Life with Disease Pelizaeus-Merzbacher disease – Diagnostics Lymphangiosarcoma – Life with Disease Sarcoma – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Synovial sarcoma metastatic – Basic Information Osteosarcoma metastatic – Life with Disease Bronchopulmonary dysplasia – Trials in Disease Sjogren’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lactic Acid Ursodoxicoltaurine Tasipimidine Olodaterol Azelastine Nirogacestat Hydrobromide CHLOROQUINE PHOSPHATE Keto-Leucine Calcium Trometamol Quetiapine Omp66 Fostemsavir OMTX705 Nepafenac ACETYLCARNITINE HYDROCHLORIDE Sabirnetug Gadoxetic Acid, Disodium Ltp001 Bi 3032950 GSKVX000000034795 More therapies…

    Learn about Your Condition

    Double hit lymphoma Abdominal infection Complex regional pain syndrome Von Hippel-Lindau disease Dilated cardiomyopathy Uterine leiomyosarcoma Hip arthroplasty Nephroblastoma Plasma cell myeloma refractory Amyloidosis Gallbladder cancer Oesophageal achalasia Kaposi's sarcoma Pneumonia chlamydial Laryngeal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. General University Hospital Of Larissa

General University Hospital Of Larissa

P. O. Box 1425, Larissa, 411 10, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Cemiplimab to Platinum-Based Chemotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cemiplimab
    • Cisplatin
    Bulgaria Czechia Greece Poland

  • Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1
    Investigated Drugs:
    • Obexelimab
    Austria Belgium Croatia Czechia Denmark Finland +4

  • Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    Austria France Germany Greece Ireland Italy +2

  • Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • EGFR gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Study of NBTXR3 and Cetuximab with Radiotherapy for Elderly Patients with Advanced Head and Neck Cancer Not Eligible for Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cetuximab
    Czechia Germany Greece

  • Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    Germany Greece The Netherlands Romania

  • Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Austria Czechia France Greece Italy Poland +2

  • Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atezolizumab
    Belgium Czechia France Germany Greece Ireland +3

  • Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8
Previous Page
1 … 13 14 15 16 17 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!